Comments on FINRA Rulemaking

Self-Regulatory Organizations; Notice of Filing and Immediate Effectiveness of a Proposed Rule Change to Amend FINRA Rule 2251 (Processing and Forwarding of Proxy and Other Issuer-Related Materials)

Filter comments

Date Received
Date Letter Type Commenter Name
Public Comment Paul T. Quinlan, General Counsel and Corporate Secretary, CymaBay Therapeutics, Inc.

Last Reviewed or Updated: Dec. 18, 2025

File Number
SR-FINRA-2021-032
Release Number
34-93769
Related Materials
How to submit comments